PNC FINANCIAL SERVICES GROUP, INC. - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 35 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$44,646
+158.4%
57,534
-0.1%
0.00%
Q4 2022$17,278
-40.4%
57,594
+0.1%
0.00%
Q3 2022$29,000
-12.1%
57,5340.0%0.00%
Q2 2022$33,000
-55.4%
57,5340.0%0.00%
Q1 2022$74,000
+12.1%
57,5340.0%0.00%
Q4 2021$66,000
+10.0%
57,534
+47.4%
0.00%
Q3 2021$60,00039,034
+134500.0%
0.00%
Q3 2019$0290.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 51,989$79,543,0000.24%
ASSET MANAGEMENT CORP /IL/ /ADV 133,500$204,0000.10%
Ikarian Capital, LLC 553,273$847,0000.06%
McAdam, LLC 55,978$86,0000.01%
JGP Wealth Management, LLC 15,000$23,0000.01%
Prospera Financial Services Inc 30,300$46,0000.00%
Fort Point Capital Partners LLC 10,000$15,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 55,599$85,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 6,501$10,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,800$76,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders